» Articles » PMID: 33807489

Reproductive Chances of Men with Azoospermia Due to Spermatogenic Dysfunction

Overview
Journal J Clin Med
Specialty General Medicine
Date 2021 Apr 3
PMID 33807489
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Non-obstructive azoospermia (NOA), or lack of sperm in the ejaculate due to spermatogenic dysfunction, is the most severe form of infertility. Men with this form of infertility should be evaluated prior to treatment, as there are various underlying etiologies for NOA. While a significant proportion of NOA men have idiopathic spermatogenic dysfunction, known etiologies including genetic disorders, hormonal anomalies, structural abnormalities, chemotherapy or radiation treatment, infection and inflammation may substantively affect the prognosis for successful treatment. Despite the underlying etiology for NOA, most of these infertile men are candidates for surgical sperm retrieval and subsequent use in intracytoplasmic sperm injection (ICSI). In this review, we describe common etiologies of NOA and clinical outcomes following surgical sperm retrieval and ICSI.

Citing Articles

Novel STAG3 variant causes oligoasthenoteratozoospermia with high sperm aneuploidy rate.

Tsabai P, Pavlova N, Shatylko T, Kumykova Z, Stupko O, Kochetkova T J Assist Reprod Genet. 2025; .

PMID: 39932630 DOI: 10.1007/s10815-025-03417-5.


The role of inflammasome dysregulation in obstructive and non-obstructive azoospermia: a comparative molecular analysis of blood, tissue, and seminal plasma.

Mirghanizadeh Bafghi S, Fesahat F, Zare F, Imani M, Vahidi S, Ansariniya H Front Immunol. 2024; 15:1507885.

PMID: 39712014 PMC: 11659152. DOI: 10.3389/fimmu.2024.1507885.


Role of Platelet-Rich Plasma in the Management of Non-obstructive Azoospermia.

Alharbi B Cureus. 2024; 16(9):e69387.

PMID: 39403643 PMC: 11472207. DOI: 10.7759/cureus.69387.


Improving Fertility in Non-obstructive Azoospermia: Results from an Autologous Bone Mar-row-Derived Mesenchymal Stromal/Stem Cell Phase I Clinical Trial.

Zhankina R, Zhanbyrbekuly U, Askarov M, Zare A, Jafari N, Saipiyeva D Int J Fertil Steril. 2024; 18(Suppl 1):60-70.

PMID: 39033372 PMC: 11263852. DOI: 10.22074/ijfs.2023.2005045.1480.


Non-invasive biomarkers for sperm retrieval in non-obstructive patients: a comprehensive review.

Fontana L, Sirchia S, Pesenti C, Colpi G, Miozzo M Front Endocrinol (Lausanne). 2024; 15:1349000.

PMID: 38689732 PMC: 11058837. DOI: 10.3389/fendo.2024.1349000.


References
1.
Ishikawa T, Shiotani M, Izumi Y, Hashimoto H, Kokeguchi S, Goto S . Fertilization and pregnancy using cryopreserved testicular sperm for intracytoplasmic sperm injection with azoospermia. Fertil Steril. 2008; 92(1):174-9. DOI: 10.1016/j.fertnstert.2008.04.051. View

2.
Chen X, Ma Y, Zou S, Wang S, Qiu J, Xiao Q . Comparison and outcomes of nonobstructive azoospermia patients with different etiology undergoing MicroTESE and ICSI treatments. Transl Androl Urol. 2019; 8(4):366-373. PMC: 6732089. DOI: 10.21037/tau.2019.04.08. View

3.
Schmidt K, Larsen E, Bangsboll S, Meinertz H, Carlsen E, Nyboe Andersen A . Assisted reproduction in male cancer survivors: fertility treatment and outcome in 67 couples. Hum Reprod. 2004; 19(12):2806-10. DOI: 10.1093/humrep/deh518. View

4.
Nicopoullos J, Gilling-Smith C, Almeida P, Ramsay J . The results of 154 ICSI cycles using surgically retrieved sperm from azoospermic men. Hum Reprod. 2004; 19(3):579-85. DOI: 10.1093/humrep/deh092. View

5.
Sakkas D . Novel technologies for selecting the best sperm for in vitro fertilization and intracytoplasmic sperm injection. Fertil Steril. 2013; 99(4):1023-9. DOI: 10.1016/j.fertnstert.2012.12.025. View